Doximity, Inc. (NASDAQ:DOCS) Shares Bought by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans grew its position in Doximity, Inc. (NASDAQ:DOCS) by 31.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 40,609 shares of the company’s stock after acquiring an additional 9,618 shares during the period. Thrivent Financial for Lutherans’ holdings in Doximity were worth $2,169,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. FMR LLC increased its stake in shares of Doximity by 30.5% in the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after purchasing an additional 1,598,602 shares in the last quarter. Lord Abbett & CO. LLC purchased a new stake in shares of Doximity in the third quarter valued at approximately $29,453,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Doximity in the third quarter valued at approximately $24,691,000. Geode Capital Management LLC raised its stake in shares of Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after buying an additional 472,565 shares during the period. Finally, Retirement Systems of Alabama lifted its position in shares of Doximity by 254.3% during the 3rd quarter. Retirement Systems of Alabama now owns 534,256 shares of the company’s stock valued at $23,278,000 after buying an additional 383,480 shares in the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 37.40% of the company’s stock.

Doximity Price Performance

Shares of DOCS stock opened at $58.40 on Friday. The company has a market capitalization of $10.90 billion, a PE ratio of 58.40, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. The firm’s 50-day moving average is $65.48 and its two-hundred day moving average is $54.30. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21.

Wall Street Analyst Weigh In

A number of research firms have weighed in on DOCS. Raymond James restated an “outperform” rating and set a $83.00 price objective (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Mizuho upped their price target on shares of Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. The Goldman Sachs Group lifted their price objective on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Canaccord Genuity Group increased their target price on Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a report on Friday, February 7th. Finally, Needham & Company LLC lifted their price target on Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Doximity presently has an average rating of “Moderate Buy” and a consensus target price of $64.22.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.